Interferon alfa-2b biosimilar (NPO Petrovax Pharm)

干扰素α-2b生物类似药 (NPO Petrovax Pharm)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa-2b biosimilar (NPO Petrovax Pharm)

Drug Alias NameInterferon alfa-2b follow-on biologic (NPO Petrovax Pharm)干扰素α-2b生物仿制药 (NPO Petrovax Pharm)Azoxiferon

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsHepatitis CHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesPetrovax Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPetrovax Pharma

Active IndicationsN/A

Inactive IndicationsHepatitis CHepatitis B

ATC CodeL03AB05